Cargando...
Personalized Pharmacotherapy for Bipolar Disorder: How to Tailor Findings From Randomized Trials to Individual Patient-Level Outcomes
The quest for “personalized medicine” in psychiatry has focused mainly on pursuing potential biomarkers such as pharmacogenetic predictors of drug response. However, the collective randomized trial database across phases of bipolar disorder allows one to identify clinical characteristics that inform...
Guardado en:
| Publicado en: | Focus (Am Psychiatr Publ) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Psychiatric Association
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6999206/ https://ncbi.nlm.nih.gov/pubmed/32047366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.focus.20190005 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|